OTC · Healthcare
Charlie's Holdings, Inc. (CHUC)
As-reported financials and recent SEC filings for Charlie's Holdings, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$20.9M
Net income
$4.5M
Net margin
21.5%
Diluted EPS
$0.02
ROE
131.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $20.9M | $7.8M | $16.3M | $26.4M | $21.5M |
| Gross profit | $5.7M | $2.9M | — | — | — |
| Operating income | $-2.2M | $-3.3M | $-2.2M | $-1.8M | $565,000 |
| Net income | $4.5M | $-4.2M | $-2.1M | $-1.6M | $4.8M |
| Diluted EPS | $0.02 | $-0.02 | $-0.01 | $-0.01 | $0.01 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-05
View on EDGAR →8-K2026-05-21
View on EDGAR →10-Q2026-05-20
View on EDGAR →NT 10-Q2026-05-15
View on EDGAR →DEF 14A2026-04-20
View on EDGAR →PRE 14A2026-04-09
View on EDGAR →NT 10-K2026-04-01
View on EDGAR →10-K2026-04-01
View on EDGAR →Largest Healthcare peers
Go deeper on CHUC
Search Charlie's Holdings, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.